Search

Your search keyword '"Insomnia -- Drug therapy"' showing total 10 results
Start Over Descriptor "Insomnia -- Drug therapy" Journal clinical psychiatry news
10 results on '"Insomnia -- Drug therapy"'

1. Swell in off-label antipsychotic prescribing 'not harmless'

Author

Yasgur, Batya Swift

Subjects
Drug therapy, Complications and side effects, Risk factors, Patient outcomes, Dosage and administration, Forecasts and trends, Market trend/market analysis, Antipsychotic agents -- Dosage and administration -- Complications and side effects, Insomnia -- Drug therapy, Anxiety -- Drug therapy, Cardiovascular diseases -- Risk factors -- Patient outcomes, Off label prescribing -- Forecasts and trends -- Complications and side effects, Off-label prescribing -- Forecasts and trends -- Complications and side effects, Antipsychotic drugs -- Dosage and administration -- Complications and side effects
Abstract

FROM THE JOURNAL OF PSYCHIATRIC RESEARCH A growing trend of off-label, low-dose antipsychotic prescribing to treat disorders such as anxiety and insomnia has been tied to an increased risk of [...]

Published
2022

2. Drug improves sleep induction without sedation

Author

Jancin, Bruce

Subjects
Drug therapy, Usage, Insomnia -- Drug therapy, Melatonin -- Usage
Abstract

DENVER -- The novel melatonin receptor agonist ramelteon was associated with significant reductions in the time it took to fall asleep in two phase III clinical trials totaling 1,234 adults [...]

Published
2005

3. Sleep may be target in treatment of PTSD

Author

Mahoney, Diana

Subjects
Drug therapy, Insomnia -- Drug therapy, Post-traumatic stress disorder -- Drug therapy
Abstract

BOSTON -- Sleep disturbances may be an important target for treating posttraumatic stress disorder, according to Dr. R. Bruce Lydiard of the Medical University of South Carolina in Charleston. Persistent, [...]

Published
2010

4. Two-drug regimen eases anxiety and insomnia

Author

Splete, Heidi

Subjects
Sepracor Inc., Drug therapy, Medical research, Insomnia -- Drug therapy, Anxiety -- Drug therapy, Pharmaceutical industry, Medicine, Experimental
Abstract

MINNEAPOLIS -- Treatment with both eszopiclone and escitalopram significantly improved the symptoms of insomnia and anxiety--compared with escitalopram alone, according to data from 595 adults presented at the annual meeting [...]

Published
2007

5. Ramelteon is effective for some insomnia patients

Author

McNamara, Damian

Subjects
Drug therapy, Health aspects, Ramelteon -- Health aspects, Insomnia -- Drug therapy
Abstract

ORLANDO -- Ramelteon is effective for a subset of patients with insomnia, according to a presentation at a psychopharmacology congress sponsored by the Neuroscience Education Institute. In addition, because the [...]

Published
2007

6. Abundance of insomnia therapies in the pipeline

Author

Jancin, Bruce

Subjects
Drug therapy, Product development, Insomnia -- Drug therapy, Hypnotics and sedatives -- Product development, Pharmaceutical industry -- Product development, Hypnotics -- Product development, Sedatives -- Product development
Abstract

DENVER -- The pharmaceutical industry envisions the insomnia market as a field of dreams, judging by the sizable array of agents moving through the developmental pipeline. And these aren't 'me-too' [...]

Published
2005

7. Novel drug shows promise for sleep initiation, maintenance

Author

Jancin, Bruce

Subjects
Drug therapy, Product development, Insomnia -- Drug therapy, Hypnotics and sedatives -- Product development, Hypnotics -- Product development, Sedatives -- Product development
Abstract

DENVER -- Gaboxadol significantly improved sleep initiation and maintenance while also increasing time spent in restorative slow-wave sleep in an acute phase II placebo-controlled trial, Stephen Deacon, Ph.D., reported at [...]

Published
2005

8. Ambien CR approved for insomnia

Subjects
Ambien (Medication) -- Dosage and administration -- Licensing, certification and accreditation, Drug therapy, Dosage and administration, Licensing, certification and accreditation, Insomnia -- Drug therapy, Hypnotics and sedatives -- Dosage and administration -- Licensing, certification and accreditation, Hypnotics -- Dosage and administration -- Licensing, certification and accreditation, Sedatives -- Dosage and administration -- Licensing, certification and accreditation
Abstract

Ambien CR (zolpidem tartrate extended-release tablets) has been approved for the treatment of insomnia. The tablets are available in both 6.25-mg and 12.5-mg strengths. For more information, contact Sanofi-Aventis by [...]

Published
2005

9. FDA approves melatonin agonist for insomnia

Author

Mechcatie, Elizabeth

Subjects
Drug therapy, Insomnia -- Drug therapy, Central nervous system agents, Drug approval
Abstract

The Food and Drug Administration has approved an insomnia drug with a unique mechanism of action and several features unique among hypnotics approved for insomnia: It is not a controlled [...]

Published
2005

10. FDA approves new sleep aid

Author

Ault, Alicia

Subjects
Sepracor Inc. -- Licensing, certification and accreditation, United States. Food and Drug Administration -- Powers and duties, Powers and duties, Drug therapy, Licensing, certification and accreditation, Insomnia -- Drug therapy, Pharmaceutical industry -- Licensing, certification and accreditation, Drug approval
Abstract

The Food and Drug Administration has approved a new, nonnarcotic therapy for insomnia, eszopiclone. Most sleep aids are approved for only short-term use of a week to 10 days, but [...]

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results